IL-27 Regulates IL-18 binding protein in skin resident cells.

IL-18 is an important mediator involved in chronic inflammatory conditions such as cutaneous lupus erythematosus, psoriasis and chronic eczema. An imbalance between IL-18 and its endogenous antagonist IL-18 binding protein (BP) may account for increased IL-18 activity. IL-27 is a cytokine with dual...

Full description

Bibliographic Details
Main Authors: Miriam Wittmann, Rosella Doble, Malte Bachmann, Josef Pfeilschifter, Thomas Werfel, Heiko Mühl
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3384590?pdf=render
_version_ 1811264686346207232
author Miriam Wittmann
Rosella Doble
Malte Bachmann
Josef Pfeilschifter
Thomas Werfel
Heiko Mühl
author_facet Miriam Wittmann
Rosella Doble
Malte Bachmann
Josef Pfeilschifter
Thomas Werfel
Heiko Mühl
author_sort Miriam Wittmann
collection DOAJ
description IL-18 is an important mediator involved in chronic inflammatory conditions such as cutaneous lupus erythematosus, psoriasis and chronic eczema. An imbalance between IL-18 and its endogenous antagonist IL-18 binding protein (BP) may account for increased IL-18 activity. IL-27 is a cytokine with dual function displaying pro- and anti-inflammatory properties. Here we provide evidence for a yet not described anti-inflammatory mode of action on skin resident cells. Human keratinocytes and surprisingly also fibroblasts (which do not produce any IL-18) show a robust, dose-dependent and highly inducible mRNA expression and secretion of IL-18BP upon IL-27 stimulation. Other IL-12 family members failed to induce IL-18BP. The production of IL-18BP peaked between 48-72 h after stimulation and was sustained for up to 96 h. Investigation of the signalling pathway showed that IL-27 activates STAT1 in human keratinocytes and that a proximal GAS site at the IL-18BP promoter is of importance for the functional activity of IL-27. The data are in support of a significant anti-inflammatory effect of IL-27 on skin resident cells. An important novel property of IL-27 in skin pathobiology may be to counter-regulate IL-18 activities by acting on keratinocytes and importantly also on dermal fibroblasts.
first_indexed 2024-04-12T20:07:40Z
format Article
id doaj.art-26852842a75d44c0a57ab34c4222d3b3
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-04-12T20:07:40Z
publishDate 2012-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-26852842a75d44c0a57ab34c4222d3b32022-12-22T03:18:19ZengPublic Library of Science (PLoS)PLoS ONE1932-62032012-01-0176e3875110.1371/journal.pone.0038751IL-27 Regulates IL-18 binding protein in skin resident cells.Miriam WittmannRosella DobleMalte BachmannJosef PfeilschifterThomas WerfelHeiko MühlIL-18 is an important mediator involved in chronic inflammatory conditions such as cutaneous lupus erythematosus, psoriasis and chronic eczema. An imbalance between IL-18 and its endogenous antagonist IL-18 binding protein (BP) may account for increased IL-18 activity. IL-27 is a cytokine with dual function displaying pro- and anti-inflammatory properties. Here we provide evidence for a yet not described anti-inflammatory mode of action on skin resident cells. Human keratinocytes and surprisingly also fibroblasts (which do not produce any IL-18) show a robust, dose-dependent and highly inducible mRNA expression and secretion of IL-18BP upon IL-27 stimulation. Other IL-12 family members failed to induce IL-18BP. The production of IL-18BP peaked between 48-72 h after stimulation and was sustained for up to 96 h. Investigation of the signalling pathway showed that IL-27 activates STAT1 in human keratinocytes and that a proximal GAS site at the IL-18BP promoter is of importance for the functional activity of IL-27. The data are in support of a significant anti-inflammatory effect of IL-27 on skin resident cells. An important novel property of IL-27 in skin pathobiology may be to counter-regulate IL-18 activities by acting on keratinocytes and importantly also on dermal fibroblasts.http://europepmc.org/articles/PMC3384590?pdf=render
spellingShingle Miriam Wittmann
Rosella Doble
Malte Bachmann
Josef Pfeilschifter
Thomas Werfel
Heiko Mühl
IL-27 Regulates IL-18 binding protein in skin resident cells.
PLoS ONE
title IL-27 Regulates IL-18 binding protein in skin resident cells.
title_full IL-27 Regulates IL-18 binding protein in skin resident cells.
title_fullStr IL-27 Regulates IL-18 binding protein in skin resident cells.
title_full_unstemmed IL-27 Regulates IL-18 binding protein in skin resident cells.
title_short IL-27 Regulates IL-18 binding protein in skin resident cells.
title_sort il 27 regulates il 18 binding protein in skin resident cells
url http://europepmc.org/articles/PMC3384590?pdf=render
work_keys_str_mv AT miriamwittmann il27regulatesil18bindingproteininskinresidentcells
AT roselladoble il27regulatesil18bindingproteininskinresidentcells
AT maltebachmann il27regulatesil18bindingproteininskinresidentcells
AT josefpfeilschifter il27regulatesil18bindingproteininskinresidentcells
AT thomaswerfel il27regulatesil18bindingproteininskinresidentcells
AT heikomuhl il27regulatesil18bindingproteininskinresidentcells